Sign In
test

Max Eisenberg

Versant Venture Management, Llc

Assets Managed
$141.411M
Holdings
8
Last Quarter
2026 - Q1
Filed Date
21d ago
Growth Rate
-6.38%(2Q avg: -17.64%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Versant Venture Management, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 8 positions.

Assets under management

The assets under management (AUM) of Versant Venture Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 141.411M in assets, with a quarterly growth rate of -6.38% and a 2-quarter average growth rate of -17.64%. The portfolio is managed by Max Eisenberg, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
GLUE
Monte Rosa Therapeutics Inc
Recent Activity
Decreased -27.42%
37.01%
$52.324M
3.181M shares@ $16.45 avg price
IPSC
Century Therapeutics Inc
Recent Activity
New Position
19.45%
$27.495M
12.166M shares@ $2.26 avg price
LENZ
Lenz Therapeutics Inc
Recent Activity
17.2%
$24.311M
2.657M shares@ $9.15 avg price
JBIO
Jade Biosciences Inc
Recent Activity
15.16%
$21.438M
1.526M shares@ $14.05 avg price
CTNM
Contineum Therapeutics Inc-a
Recent Activity
5.02%
$7.087M
542,628 shares@ $13.07 avg price
CRSP
Crispr Therapeutics Ag
Recent Activity
5.01%
$7.08M
148,831 shares@ $47.58 avg price
SKYE
Skye Bioscience Inc
Recent Activity
0.88%
$1.234M
2.008M shares@ $0.62 avg price
TPST
Tempest Therapeutics Inc
Recent Activity
0.32%
$442,426
269,772 shares@ $1.64 avg price

1-8 of 8